Phase 2 Study With SNF472 in Calciphylaxis Patients
Status:
Completed
Trial end date:
2017-11-15
Target enrollment:
Participant gender:
Summary
To evaluate the effect of SNF472 on top of standard of care on promoting wound healing and
other parameters of therapeutic response in haemodialysis patients with calciphylaxis
(calcific uraemic arteriolopathy, CUA).